Journal of Alzheimer's Disease - Volume 22, issue s3

Authors: Fodale, Vincenzo | Ritchie, Karen | Rasmussen, Lars S. | Mandal, Pravat K.

Article Type: Editorial

DOI: 10.3233/JAD-2010-100809

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S1-S3, 2010

Authors: Finder, Verena H.

Article Type: Review Article

Abstract: Alzheimer's disease (AD) is the most common form of dementia, which affects more than 35 million people worldwide with increasing tendency. Satisfying therapies and prevention are not available. Since the first description of the fatal progressive neurodegenerative disease in 1907, however, major findings on the molecular mechanisms have been reported. Current clinical trials target diverse aspects and principles of AD, such as the generation and aggregation of amyloid-β (Aβ). Extracellular amyloid plaques, predominantly consisting of Aβ, and intracellular neurofibrillar tangles, formed by hyperphosphorylated tau, are the major pathological hallmarks in the brain of AD patients. AD is consequently one of …about 40 identified amyloidoses – protein misfolding diseases, which share as their main pathogenic mechanism the aberrant deposition of endogenous proteins as amyloid fibrils. This article aims principally to introduce AD and its identified key players, to summarize classic and recent publications on the complex molecular mechanisms underlying the disease, and to discuss challenges that need to be faced for the development of improved therapeutic strategies. Show more

Keywords: Alzheimer's disease, amyloid-β, amyloid-β protein precursor, fibrils, protein misfolding, oligomers, neurotoxicity, tau

DOI: 10.3233/JAD-2010-100975

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S5-S19, 2010

Authors: Eckel, Barbara | Blobner, Manfred | Rammes, Gerhard

Article Type: Review Article

Abstract: At present, more than 35 million people worldwide have Alzheimer's disease (AD). With increasing incidence and a growing number of aged patients undergoing surgery, the relevance of a possible interaction between anesthetics and AD is growing as well. Below, we review in vitro studies investigating the effects of anesthetics on the metabolism of amyloid precursor protein and its metabolite amyloid-β.

Keywords: Alzheimer's disease, amyloid, amyloid-β protein precursor, anesthetics, in vitro

DOI: 10.3233/JAD-2010-100984

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S21-S26, 2010

Authors: Mandal, Pravat K. | Ahuja, Manisha

Article Type: Research Article

Abstract: Laboratory research on anesthetic-induced structural changes of amyloid beta (Aβ) peptide, from normal monomeric α-helix to the micro-aggregated form, has generated much interest in the scientific community as Aβ oligomerization is considered a key step in Alzheimer disease pathogenesis. A comprehensive review of the interactions of Aβ peptide with anesthetics of different molecular sizes is summarized as follows. Smaller sized anesthetics could access and perturb the cavity containing crucial amino acid residues G29, A30 and I31 of Aβ peptide leading to Aβ oligomerization. However, bulkier sized anesthetics are sterically hindered from accessing the cavity containing these crucial residues and do …not initiate Aβ oligomerization. Notably, when a small sized anesthetic is co-administered with a larger sized one, the latter does not prevent access of the small sized anesthetic to the cavity. The results of these biophysical studies are supported by animal model studies which indicate that inhaled small molecular anesthetics induce enhanced Aβ plaque deposition in transgenic mice with AD pathology. In this review, a molecular pathway for the A$\beta $-anesthetic interaction at the atomic level is presented. Show more

Keywords: Anesthetics, molecular size, NMR, Abeta, oligomerization, Alzheimer disease

DOI: 10.3233/JAD-2010-101128

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S27-S34, 2010

Authors: Schifilliti, Daniela | Santamaria, Letterio B. | Rosa, Giovanni | Di Nino, Gianfranco | Mandal, Pravat K. | Fodale, Vincenzo

Article Type: Review Article

Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the accumulation and aggregation of amyloid-β peptide and loss of forebrain cholinergic neurons, resulting in progressive loss of memory and irreversible impairment of higher cognitive functions. Several studies have accounted for the close relationship between AD and the central cholinergic system, suggesting that a dysfunction of acetylcholine containing neurons in the brain contributes significantly to the cognitive deficit of individuals with AD. The aim of the present review is to survey current literature on this topic in order to provide a clear understanding of the role of the cholinergic system in …the development and neurodegenerative process of AD. The implications for anesthesia are also discussed. This knowledge could be valuable to improve anesthesia performance and patient safety. Show more

Keywords: Alzheimer's disease, amyloid-β peptide, anesthesia, anesthetics, central cholinergic system, cholinergic receptors, liaison, neurodegenerative disorders, oligomerization

DOI: 10.3233/JAD-2010-101317

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S35-S41, 2010

Authors: Mena, María Ángeles | Perucho, Juan | Rubio, Isabel | de Yébenes, Justo Garcia

Article Type: Review Article

Abstract: Recent clinical studies have suggested that there is an increased risk of Alzheimer's disease (AD) in patients undergoing surgical interventions, but it is unknown whether this effect is related to anesthesia, cardiovascular complications of surgery, or associated conditions such as hypothermia. In addition, many patients, especially the elderly, present persistent post-operative cognitive deterioration after anesthesia, without clear complications during surgery. Experimental studies in animals may be helpful to dissect the pathogenic role of the different factors involved in surgery. Here, we review studies on the effects of anesthesia on neuronal function performed in tissue culture and in experimental animals. Several …studies have shown that a small inhalation of anesthetics induces activation of caspases and cell toxicity on glioma and pheochromocitoma cells in culture, which is prevented by treatment with the metal chelating agent clioquinol. Exposure of old rodents to anesthesia produced memory deficits and increased levels of amyloid-β (Aβ) peptide and phosphorylated tau in brain. The effects of long term or short term repetitive exposure to small molecular weight anesthetics are more severe in transgenic AβPPswe than in wild type mice. In the former, low molecular weight increased the number of TUNEL+ apoptotic cells and the ratio of pro-apoptotic proteins in hippocampus; reduced astroglial and increased microglial responses; increased Aβ aggregates and high molecular weight peptides; abnormal chaperone responses and reduced autophagy. In conclusion, anesthetic gases induce changes which may reproduce AD pathology in mice with mutations which produced AD. It would be interesting to know whether anesthetics are risky for subjects with special genetic risk factors. Show more

Keywords: Alzheimer's disease, amyloid pathology, AβPPswe mice, apoptotic cell death, autophagy, cognitive deficits, chaperones, glial cells, isoflurane, post operative cognitive dysfunction, presenilin-1

DOI: 10.3233/JAD-2010-100822

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S43-S48, 2010

Authors: Run, Xiaoqin | Liang, Zhihou | Gong, Cheng-Xin

Article Type: Review Article

Abstract: Recent studies have suggested that general anesthesia may initiate or accelerate cognitive impairment and Alzheimer's disease (AD). To understand the possible underlying mechanisms, several studies have been carried out in animal models. In this review, we first briefly discuss the mechanisms leading to neurodegeneration and cognitive impairment in AD, with an emphasis on tau abnormalities in this pathological process. Subsequently, we review the role of anesthesia in inducing tau abnormalities and the possible mechanisms. Recent studies suggest that anesthesia may accelerate the development of AD by promoting abnormal hyperphosphorylation of tau. Further studies are certainly needed to understand the molecular …mechanism by which anesthesia may initiate or accelerate cognitive impairment and AD. An understanding of the mechanism will help develop strategies for preventing or eliminating this adverse effect of anesthesia. Show more

Keywords: Alzheimer's disease, anesthesia, phosphorylation, tau

DOI: 10.3233/JAD-2010-100813

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S49-S55, 2010

Authors: Tripathi, Manjari | Vibha, Deepti

Article Type: Review Article

Abstract: The evaluation and management of patients with cognitive decline pose many diagnostic and therapeutic challenges. While most cognitive disorders need a standard screening for common reversible causes, the diagnosis of `not so usual' causes are delayed and often missed. It is important to be aware of such clinical scenarios, especially since a lot of these are reversible. Many coexisting metabolic, nutritional, endocrinal, toxic, and infectious causes mask the subtle and progressive cognitive changes that become apparent with stress and in the post operative period, often after a major surgery. Many more metabolic, nutritional, endocrinal, toxic, post operative, autoimmune, cerebrovascular, genetic, …infectious, and hemorheological factors are now emerging as unusual causes. This review deals with the recognition and evaluation of these unusual causes of cognitive decline. Show more

Keywords: Cognition, dementia, risk factors

DOI: 10.3233/JAD-2010-100828

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S57-S65, 2010

Authors: Mason, Sam Ewan | Noel-Storr, Anna | Ritchie, Craig William

Article Type: Research Article

Abstract: Post-operative cognitive complications such as delirium have been consistently associated with poor short and long term outcomes, and the role of anesthesia, particularly the role of general versus regional anesthesia, remains unclear. The objective of this systematic review with meta-analysis was to compare the influence of general, regional, or a combination of anesthesia on the development of Post-Operative Cognitive Dysfunction (POCD) and Post-Operative Delirium (POD). Standard bibliographic databases were searched and complimented by hand searching of original and review article references. Included studies were randomized controlled trials comparing general to regional (spinal, epidural, or intravenous block) or a combination of …these in a cohort who were pre-operatively cognitively normal and had an average age exceeding fifty. Where POD was the principle outcome, studies must have employed the DSM or ICD criteria. Where POCD was the principal outcome, this was defined as any objective cognitive impairment. Twenty one studies were considered suitable for inclusion. There was no effect of anesthesia type on the odds ratio of developing POD (0.88, 0.51–1.51 with 95% confidence) however general anesthesia was marginally non-significantly associated with POCD (odds ratio of 1.34, 0.93–1.95 with 95% confidence). There was no evidence of publication bias. In conclusion, it appears that general anesthesia, compared to others, may increase the risk of developing POCD; however this has not been shown for POD. Possible reasons for this finding have been explored. This data would advocate for the use of regional anesthesia wherever possible especially in people otherwise vulnerable to developing cognitive symptoms. Show more

Keywords: Confusion, delirium, epidural anesthesia, general anesthesia, post-operative period, spinal anesthesia

DOI: 10.3233/JAD-2010-101086

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S67-S79, 2010

Authors: Bilotta, Federico | Doronzio, Andrea | Stazi, Elisabetta | Titi, Luca | Fodale, Vincenzo | Di Nino, Gianfranco | Rosa, Giovanni

Article Type: Review Article

Abstract: Alzheimer's disease (AD), a chronic and progressive deterioration of memory and other cognitive domains, is the most common form of dementia. Because of related health and social impact, there is growing interest in assessing potential relationship between anesthesia and the onset and progression of chronic neurodegenerative disorders, including AD. Currently, preclinical and clinical research is addressed to identify underlying pathomechanisms, patient risk factors, and the use of the least provocative drugs and techniques, to minimize the incidence of chronic neurodegenerative disorders. Preclinical studies are providing an increasing body of evidences on some of the mechanisms that link anesthetics to neuronal …programmed cell death (apoptosis) and accumulation of misfolded proteins in the aging brain. Therefore, risk factors and pathomechanisms of chronic neurodegenerative disorders, including AD, and persistent postoperative-postanesthesia cognitive dysfunction may overlap. Show more

Keywords: Alzheimer's disease, postanesthesia cognitive dysfunction, postoperative delirium

DOI: 10.3233/JAD-2010-100825

Citation: Journal of Alzheimer's Disease, vol. 22, no. s3, pp. S81-S89, 2010